镇静
咪唑安定
芬太尼
医学
异丙酚
谵妄
加药
重症监护室
麻醉
重症监护医学
不利影响
药理学
作者
Niloufar Eghbali,Tuka Alhanai,Mohammad M. Ghassemi
标识
DOI:10.1109/bhi58575.2023.10313431
摘要
Common treatments in Intensive Care Units frequently involve prolonged sedation. Maintaining adequate sedation levels is challenging and prone to errors including: incorrect dosing, omission/delay in administration and, selecting a sub-optimal combination of sedatives. In this single-center retrospective study of 1,346 patients, we use a Deep Q Network approach to develop a multi-objective sedation management agent. The agent's objective was to achieve an adequate level of patient sedation without moving the patient's Mean Arterial Pressure (MAP) outside of a therapeutic range. To achieve this objective, the agent was allowed to periodically (every 4 hours) recommend how the dose of two commonly used sedatives (propofol, midazolam) and an opioid (fentanyl) should be adjusted: increased, decreased, or stay the same. To inform it's recommendations, the agent was provided with the patient's demographym and periodic measures including: vital signs, and depth of sedation. To mitigate the potential risk of delirium and the adverse effects of over sedation, a delirium control variable was integrated into the agent's reward function. We found that Physicians with dosing policies that agreed with our agent were 29% more likely to maintain the patient's sedation in a therapeutic range, compared to those that disagreed with our agent's policy.
科研通智能强力驱动
Strongly Powered by AbleSci AI